Similar articles

• Gemfibrozil as a lipid lowering compound in hyperlipoproteinaemia. A placebo-controlled cross-over trial.

  Vessby B, Lithell H, Boberg J, Hellsing K, Werner I. Vessby B, et al. Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):32-7. doi: 10.1177/00359157760690S208. Proc R Soc Med. 1976. PMID: 798194 Free PMC article. Clinical Trial.
• Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.

  Eisalo A, Manninen V. Eisalo A, et al. Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):44-6. doi: 10.1177/00359157760690S211. Proc R Soc Med. 1976. PMID: 798196 Free PMC article. Clinical Trial. No abstract available.
• A long-term trial of gemfibrozil in the treatment of hyperlipidaemias.

  Eisalo A, Manninen V. Eisalo A, et al. Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):49-52. doi: 10.1177/00359157760690S213. Proc R Soc Med. 1976. PMID: 798198 Free PMC article. Clinical Trial. No abstract available.
• The use of gemfibrozil in the treatment of primary hyperlipoproteinaemia. Preliminary report.

  Honorato J, Masso RM, Purroy A. Honorato J, et al. Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):78-9. doi: 10.1177/00359157760690S219. Proc R Soc Med. 1976. PMID: 798200 Free PMC article. Clinical Trial. No abstract available.
• Does hypolipidemic therapy prevent coronary heart disease?

  Rifkind BM, Levy RI. Rifkind BM, et al. Cardiovasc Clin. 1974;6(2):1-8. Cardiovasc Clin. 1974. PMID: 4374303 Review. No abstract available.